In patients with HIV infection on rifampicin TB therapy, twice-daily bictegravir/emtricitabine/tenofovir alafenamide results ...
ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of the IPACE ...
An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...
A mix of domestic revenue generation, efficiency gains and strategic partnerships is essential to sustain and expand HIV ...
From chart-topping beats to a life-altering diagnosis, Ugandan hitmaker Didi faced viral stigma and chose to fight back, ...
If the test does show a positive result for HIV antibodies, the SHA recommends taking a standard HIV test from a health-care ...
The New Times on MSN
New HIV infections down 12% amid prevention efforts
Rwanda recorded 2,555 new HIV infections in 2024, down from 2,922 cases in 2023, according to data obtained from the Rwanda Biomedical Centre (RBC). This marks a 12.5 per cent decline that underscores ...
That experience moved Hurley to seek out PrEP, shorthand for preexposure prophylaxis. The antiretroviral medication greatly ...
‘Can I get HIV if we share this sandwich?’ The question arrived without warning – no drumroll, no build-up, just slipped ...
The World Health Organization (WHO) has released updated recommendations on HIV clinical management providing new and revised guidance on ...
The scale-up of HIV treatment and prevention programs has led to remarkable declines in orphanhood rates in Rakai, Uganda, ...
There’s opportunity at hand to make sure one of the last century’s biggest healthcare travesties isn’t repeated, and long-term care is at the heart of it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results